Vaccine development and technology for SARS‐CoV‐2: Current insight-Reference-Cited by-同舟云学术

Vaccine development and technology for SARS‐CoV‐2: Current insight

Published:2021-11-11 Issue:3 Volume:94 Page:878-896
ISSN:0146-6615
Container-title:Journal of Medical Virology
language:en
Short-container-title:Journal of Medical Virology

Author:

Cattel Luigi¹^ORCID,Giordano Susanna²^ORCID,Traina Sara²,Lupia Tommaso³,Corcione Silvia⁴⁵,Angelone Lorenzo⁶,La Valle Giovanni⁶,De Rosa Francesco G.³⁵,Cattel Francesco²

Affiliation:

1. Department of Drug Science and Technology University of Turin Turin Italy

2. Department of Hospital Pharmacy Città della Salute e della Scienza Turin Italy

3. Infectious Diseases Unit Cardinal Massaia Hospital Asti Italy

4. Department of Medical Sciences Tufts University School of Medicine Boston Massachusetts USA

5. Department of Medical Sciences, Infectious Diseases, Città della Salute e della Scienza University of Turin Turin Italy

6. General Management Città della Salute e della Scienza Turin Italy

Publisher

Wiley

Subject

Infectious Diseases,Virology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jmv.27425

Reference104 articles.

1. A novel coronavirus outbreak of global health concern

2. 2019 novel coronavirus (2019-nCoV) outbreak: A new challenge

3. COVID‐19 dashboard. Accessed August 6 2021. https://covid19.who.int/

4. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): An overview of viral structure and host response

5. Draft landscape of COVID‐19 candidate vaccines. Accessed August 6 2021. https://www.who.int/publications/m/item/draft-landscape-of-covid-19-candidate-vaccines

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Challenges Faced by States and the WHO in Efficiently Regulating the Use of mRNA Vaccines;IECV 2023;2023-12-01

2. Sequential or Combination Treatments as Rescue Therapies in Immunocompromised Patients with Persistent SARS-CoV-2 Infection in the Omicron Era: A Case Series;Antibiotics;2023-09-19

3. A Trim-RBD-GEM vaccine candidate protects mice from SARS-CoV-2;Virology;2023-08

4. Vaccinia Virus Strain MVA Expressing a Prefusion-Stabilized SARS-CoV-2 Spike Glycoprotein Induces Robust Protection and Prevents Brain Infection in Mouse and Hamster Models;Vaccines;2023-05-21

5. Advances in Nanomaterial-Based Platforms to Combat COVID-19: Diagnostics, Preventions, Therapeutics, and Vaccine Developments;ACS Applied Bio Materials;2022-05-18